July 18, 2016
This recent report explores key factors behind customer satisfaction and other dynamics within the Late Phase market.
June 21, 2016
Report shines light on the current state of the Phase II/III clinical trial market and its anticipated direction into 2020.
September 09, 2015
We all need help sometimes. For pharmaceutical companies, this often comes in the form of a reliable and competent contract research organization.
July 31, 2015
Accuracy in data capture methods has always been and will continue to be a foremost necessity in pharmaceutical clinical trials.
July 14, 2015
It is well known within the industry that being on a sponsor’s preferred provider list affords a critical leg up to providers hoping to win business. Phase II/III work is no exception. In the 7th edition of Industry Standard Research’s CRO Quality Benchmarking - Phase II/III Service Providers report, ISR digs a bit deeper into the dynamics of preferred provider lists and how these lists affect CRO selection for Phase II/III studies.
March 23, 2015
Despite the substantial difficulties associated with orphan drug trial recruitment, this segment of the drug development market is booming.